Spots Global Cancer Trial Database for stage iiib
Every month we try and update this database with for stage iiib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma | NCT02288897 | Cutaneous Melan... | PV-10 (10% rose... Dacarbazine, te... | 18 Years - | Provectus Pharmaceuticals | |
| A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer | NCT00970580 | Non-Small Cell ... | BIIB022 With Pa... | 18 Years - | Biogen | |
| A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers | NCT03073525 | Advanced Gyneco... Ovarian Cancer Cervical Cancer Uterine Cancer | Vigil Atezolizumab | 18 Years - | Gradalis, Inc. | |
| CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer | NCT00434031 | Breast Cancer | docetaxel cyclophosphamid... trastuzumab liposomal doxor... | 18 Years - 65 Years | National Cancer Institute, Naples | |
| Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC | NCT00226590 | Lung Cancer | Gemcitabine Carboplatin Paclitaxel Radiation | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases | NCT01114958 | Lung Neoplasms Neoplasm Metast... | Cisplatin, Thio... | 18 Years - | University of California, San Diego | |
| Dose EScalation Induction of EvERolimus | NCT02387099 | Breast Cancer Hormone Recepto... | 3 weeks Dose In... 3 weeks Convent... Open Label Phas... Standard Care a... | 18 Years - | German Breast Group | |
| MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer | NCT00799240 | Non Small Cell ... | Arm A: Pemetrex... Arm B Pemetrexe... | 18 Years - | University of Kansas Medical Center | |
| MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer | NCT00799240 | Non Small Cell ... | Arm A: Pemetrex... Arm B Pemetrexe... | 18 Years - | University of Kansas Medical Center | |
| Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer | NCT02633189 | Non-squamous No... | Erlotinib Bevacizumab | 18 Years - 70 Years | National Cancer Institute, Naples | |
| CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients | NCT00526643 | Non-Small Cell ... | gemcitabine cisplatin | 18 Years - 70 Years | National Cancer Institute, Naples | |
| A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers | NCT03073525 | Advanced Gyneco... Ovarian Cancer Cervical Cancer Uterine Cancer | Vigil Atezolizumab | 18 Years - | Gradalis, Inc. | |
| Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) | NCT03088540 | Carcinoma，Non-S... Lung Carcinomas... Non-small-cell ... Nonsmall Cell L... | Pemetrexed Paclitaxel Gemcitabine Cisplatin Carboplatin cemiplimab | 18 Years - | Regeneron Pharmaceuticals | |
| Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients | NCT01911325 | Squamous Non-sm... | Buparlisib Buparlisib matc... Docetaxel | 18 Years - | Novartis | |
| CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients | NCT00526643 | Non-Small Cell ... | gemcitabine cisplatin | 18 Years - 70 Years | National Cancer Institute, Naples | |
| mFOLFOXIRI Compared to mFOLFOX6 or CapeOx as Adjuvant Chemotherapy for Stage IIIB or IIIC Colorectal Cancer | NCT05200299 | Colorectal Canc... | mFOLFOXIRI mFOLFOX6 OR Cap... | 18 Years - 75 Years | First Affiliated Hospital of Wenzhou Medical University | |
| Erlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant Nsclc | NCT01955421 | Advanced Stage ... | Erlotinib 100mg... Gefitinib 250mg... | 18 Years - | Sun Yat-sen University | |
| Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC) | NCT00942825 | Metastatic Non-... | CBP501 + Cispla... Cisplatin + Pem... | 18 Years - | CanBas Co. Ltd. | |
| Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer | NCT02831582 | Arthralgia Breast Neoplasm... | Omega-3 Fatty A... Placebo | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer | NCT01126736 | Non Small Cell ... | eribulin mesyla... pemetrexed Eribulin mesyla... | 18 Years - | Eisai Inc. | |
| Nivolumab, BMS-936558 in Combination With Relatlimab, BMS-986016 in Patients With Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting | NCT03743766 | Melanoma | Relatlimab Nivolumab Relatlimab + Ni... | 18 Years - | University of Pittsburgh | |
| Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) | NCT03088540 | Carcinoma，Non-S... Lung Carcinomas... Non-small-cell ... Nonsmall Cell L... | Pemetrexed Paclitaxel Gemcitabine Cisplatin Carboplatin cemiplimab | 18 Years - | Regeneron Pharmaceuticals | |
| EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer | NCT00338247 | Neoplasms, Brea... | lapatinib + cap... | 18 Years - | Novartis | |
| Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases | NCT01114958 | Lung Neoplasms Neoplasm Metast... | Cisplatin, Thio... | 18 Years - | University of California, San Diego | |
| Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung | NCT02713828 | Squamous Cell C... | Phase I: Glemba... Phase II: Glemb... | 18 Years - | PrECOG, LLC. | |
| A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer | NCT00970580 | Non-Small Cell ... | BIIB022 With Pa... | 18 Years - | Biogen | |
| Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients | NCT01911325 | Squamous Non-sm... | Buparlisib Buparlisib matc... Docetaxel | 18 Years - | Novartis | |
| Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab. | NCT04381494 | Unresectable St... | Multiparametric... | 18 Years - 130 Years | AstraZeneca | |
| Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer | NCT01126736 | Non Small Cell ... | eribulin mesyla... pemetrexed Eribulin mesyla... | 18 Years - | Eisai Inc. | |
| Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer | NCT00592007 | Non Small Cell ... | Fulvestrant and... | 18 Years - | University of California, San Diego | |
| Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer | NCT02633189 | Non-squamous No... | Erlotinib Bevacizumab | 18 Years - 70 Years | National Cancer Institute, Naples | |
| Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC | NCT00226590 | Lung Cancer | Gemcitabine Carboplatin Paclitaxel Radiation | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) | NCT03088540 | Carcinoma，Non-S... Lung Carcinomas... Non-small-cell ... Nonsmall Cell L... | Pemetrexed Paclitaxel Gemcitabine Cisplatin Carboplatin cemiplimab | 18 Years - | Regeneron Pharmaceuticals | |
| Patient Function/Fitness and Psychosocial Health in Improving Health-Related Quality of Life in Patients With Stage I-IV Non-Small Cell Lung Cancer | NCT02835066 | Smoking Lung Neoplasms | Integrated Fitn... Psychosocial As... Quality-of-Life... | 18 Years - | Wake Forest University Health Sciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
